GDF15 and cancer: We hypothesized that children with newly diagnosed cancer would have elevated GDF15 levels compared to the control group, that GDF15 would increase over time with the start of cancer-directed therapies, and that increased GDF15 would be associated with detrimental changes in anthropometric measures and QOL measures, particularly those related to gastrointestinal symptoms.